|
Genome-wide summary statistics for cognitively defined late-onset Alzheimer’s disease subgroups |
|
|
|
|
Case of CBD for determining Cryo-EM structure of 4R tau |
|
|
|
|
Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease |
|
|
|
|
CSF Summary Statistics- Cruchaga et al. (2013) |
|
|
|
|
Immune-related genetic enrichment in FTD summary statistics- Broce et al. 2018 |
|
|
|
|
A fast and robust strategy to remove variant level artifacts in Alzheimer’s Disease Sequencing Project data (Belloy et al. 2022) (via DSS) |
|
|
|
|
Functional Annotation of genomic variants in studies of LOAD |
|
|
|
|
Multi-cohort study of endo-lysosomal system genetics and dementia |
|
|
|
|
Results of gene - based weighted burden analyses using SCOREASSOC and GENEVARASSOC and multivariate analyses of variants near APOE applied to the ADSP Discovery Case - Control Based Extension Study. |
|
|
|
|
A novel age-informed approach for genetic association analysis in Alzheimer’s disease summary statistics - Guen et al. 2021 |
|
|
|
|
ADGC Summary Statistics- Naj et al. (2011) |
|
|
|
|
Episodic Memory Trajectories (EMTs) of 13,037 elderly |
|
|
|
|
Novel risk loci and pathways associated with Alzheimer disease in African Americans: A GWAS and meta-analysis summary statistics- Kunkle et al. (2020) |
|
|
|
|
IGAP Rare Variant Summary Statistics- Kunkle et al. (2019) |
|
|
|
|
Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders (via DSS) |
|
|
|
|
ADGC African American Summary Statistics- Reitz et al. (2013) |
|
|
|
|
ADGC case-control summary statistics on 7050 samples not included in the IGAP-2013 discovery stage- Hu et al. (2019) |
|
|
|
|
Genetic variants and functional pathways associated with resilience to Alzheimer’s disease (via DSS) |
|
|
|
|
ADSP Discovery Case/Control Association Results |
|
|
|
|
GWAS Summary Statistics of informed conditioning analysis in African Americans- Mez et al. (2017) |
|
|
|
